The Dose Form Was the Dose
Form was the measure.
Modern dosing language begins with a number. A milligram count precedes every other consideration: how much, before the form, before the timing, before the question of what kind of encounter the preparation will produce. That sequencing feels inevitable now, but it is historically recent. For most of the period in which cannabis functioned as a clinical medicine, there were no milligrams. There was no analytical chemistry to separate a preparation into its constituent parts and assign each a quantity. What existed instead was a system of prepared forms, and those forms did the work that numbers do now. A practitioner reaching for charas rather than bhang was not choosing a stronger version of the same dose. The practitioner was choosing a different option entirely. The form was not the delivery mechanism. The form was the specification.
In this context, form did not mean shape alone. It meant the prepared state of the medicine: whether the material was leaf, flowering top, or resin; whether it was taken as a paste, tincture, electuary, or fat-based preparation; whether it was dilute or concentrated; and how that preparation was expected to behave once used. Form was the practical category through which dose was understood before dose could be measured.
That distinction is the subject of this article. Not why traditional systems preferred resin over flower, or how fats and alcohols shaped preparation. The question here is narrower and more fundamental: in the absence of measurement, what did a dose mean, and how was it held? The answer is that it was held in form. Preparation encoded what practitioners needed to know before a number could.
What Counted as a Dose
Before analytical chemistry, a dose had no molecular referent. There was no cannabinoid percentage to read from a label, no milligram quantity to calculate against body weight. A practitioner working in a pre-modern context was not operating in ignorance of this. The system they used simply did not require a molecular unit. What it required was something different: a form-specific expectation.
A defined portion of resin was a dose not because its chemical content had been measured, but because repeated use of that form had produced a recognizable range of outcomes. A spoonful of a prepared electuary was a dose for the same reason. The form carried an embedded record of experience. Practitioners were not guessing when they reached for a particular preparation in a particular amount. They were drawing on accumulated form-specific knowledge that told them, with reasonable reliability, what that material would do under ordinary conditions.
The mechanism is practical, not theoretical. In the absence of measurement, form served as the primary container for dose knowledge. A preparation did not simply contain active compounds in some quantity. It carried, in its physical character, a history of prior administrations: what had followed, how reliably, and under what conditions. That accumulated knowledge was inseparable from the form in which the preparation existed. You could not extract the dose knowledge from the preparation any more than you could extract milligrams from it. Both resided in the material as prepared.
The implication is that traditional dose knowledge was not imprecise approximation of what modern measurement later made exact. It was a different and functional system, adapted to the constraints of its context. Practitioners were not struggling toward milligrams with cruder tools. They were working within a framework where form carried meaning that numbers were not yet available to carry.
The practical consequence is that traditional systems preserved multiple forms not as cultural habit or regional variety, but because each form encoded distinct dose information. Collapsing them into a single preparation would not have made dose knowledge more precise. It would have destroyed the organizational structure through which that knowledge was held and transmitted.
The Hierarchy of Forms
Traditional cannabis medicine across South Asian, Persian, Arabic, and later European practice maintained a range of prepared forms that served as calibrated options. Bhang, ganja, charas, tinctures, electuaries, fat-based preparations: these were not interchangeable routes to the same outcome, varied only by concentration. Each form carried a different profile, and the practitioner's task was to select the appropriate one for the presenting condition and patient.
The Ayurvedic classification offers one instructive example, though its precise clinical logic is not fully recoverable from surviving texts and should not be read as a uniform system. What those sources suggest is a consistent pattern: bhang, prepared from leaf material in dilute form, was associated with gentler effects and a wider margin for error. Ganja, derived from flowering tops, occupied a middle register, stronger and requiring more deliberate handling. Charas, the collected resin, demanded the greatest care: smaller amounts, more immediate response, and less room for correction if the amount used turned out to be too much. Whether practitioners framed these distinctions in exactly these terms is not always recoverable, but the pattern across sources points in the same direction.
Understood as a dose system, this classification appears to be not primarily about potency but about predictability of response and how much tolerance the form offered for imprecision. Each form defined a different set of conditions under which use was medically reasonable. Bhang could absorb variation in the patient's constitution and in the preparation itself without producing outcomes that required urgent correction. Charas offered less of that room. The form defined the situation in which the material was appropriate, which is what a dose specification is meant to do.
The same logic extended, with variation across traditions and periods, to tinctures and fat-based preparations, which sorted by different parameters: onset timing and duration of effect. The evidence for how precisely practitioners understood these differences varies by tradition and period, but the practical observation that different forms behaved differently in the body is consistent across sources. A practitioner selecting a fat-based preparation for sustained use was selecting a form whose timing mattered. Duration was part of what the form communicated.
The implication is that the hierarchy of forms functioned as a classification of situations, not a ranking of materials. Selecting from it required judgment about the patient, the condition, the context of use, and the acceptable range of outcomes. The choice of form carried the dose judgment with it.
What the Form Carried
If the previous section establishes that forms constituted a dose system, this one asks what, exactly, a form carried. The answer has several components, and they map closely onto what any useful dose specification needs to communicate, in whatever language a medical system uses.
A prepared form carried information about onset. Practitioners using fat-based preparations would have observed a more gradual integration of effects over time than those using tinctures in alcohol. Whether this was consciously theorized or simply absorbed into practice as observed regularity, the onset behavior was embedded in the preparation's physical character and was not separable from it.
A form also carried information about intensity and duration. Charas in small amounts tended to produce clear, relatively time-limited effects. Bhang in comparable mass tended to produce effects that were milder, more diffuse, and slower to resolve. These were not simply different strengths of the same experience. They were different response profiles, and they appear to have mapped to the different forms consistently enough that the form itself could serve as a working predictor.
Perhaps most importantly, a form carried information about correction margin: how much room existed if the response exceeded what was intended. This is the component of dose knowledge that a milligram count alone cannot provide. Knowing the quantity in a preparation does not tell the practitioner how quickly it acts, how long effects will sustain, or whether there is time to intervene if something goes differently than expected. Form-encoded dose knowledge helped account for much of this. The preparation communicated not only what it would likely do, but how forgiving it would probably be.
When a practitioner selected a prepared form, these parameters arrived together. Onset, intensity, duration, and correction margin were not separate variables to be calculated independently. They were bundled in the form and transmitted with it. A dose was not a quantity extracted from a preparation and applied to a situation. It was a prepared form introduced into a situation, carrying its behavioral profile with it. The form was doing the work of specification not despite the absence of numbers, but because the absence of numbers made form the only place that kind of knowledge could reliably live.
When Dose Became Countable
The shift toward quantitative dose arrived gradually, as preparation methods became more standardized and observation more systematic. O'Shaughnessy's tincture work in the mid-nineteenth century represents one visible moment in that transition, though not its origin or its conclusion. What his approach introduced was not simply a new preparation, but a different dose framework: one in which the unit of administration was a measurable quantity of a prepared solution rather than a defined portion of a traditional form.
This was a genuine improvement in one dimension. A tincture prepared to a consistent standard could be portioned in drops, adjusted incrementally, and compared across administrations with a precision that weight-based portions of resin or dried material could not easily match. The move toward quantitative dose made the administered amount more reproducible and more communicable between practitioners who had never examined the same patient.
The problem was not measurement. Measurement was useful and remains so. The problem was subtler: as dose became expressible as a number, the other information that form had been carrying became harder to hold within the primary vocabulary of practice. Onset timing, duration, correction margin, the behavioral envelope the preparation would produce: these did not disappear immediately. But they receded from the vocabulary through which dose was discussed, recorded, and transmitted. A milligram count is precise about quantity. It is silent about everything else the form was communicating.
Pharmaceutical standardization built further on this logic. Dose came to mean a specific amount of an identified compound delivered by a specified route. That framework works well for medicines that behave predictably regardless of their physical presentation. Cannabis complicated it. Preparations with similar milligram counts produced different outcomes across patients and contexts. The response within standardized medicine was usually to refine the number: purer extracts, tighter dose ranges, more controlled delivery. What was less often asked is whether some of the variability was not error in the quantity measurement, but signal in the preparation form that the dose vocabulary no longer had room to describe.
That is the shift worth marking. Not that counting was wrong, but that once dose became a number, form became easy to treat as secondary. Preparation was reclassified as a pharmacokinetic variable rather than recognized as a primary component of the dose itself. The two had always been inseparable in practice. They became separable in language, and that separation changed what medicine was paying attention to.
The Form Still Matters
The argument that form-encoded dose is merely a historical artifact rests on the assumption that the body has changed how it encounters prepared materials. It has not. A preparation introduced into a biological system does not declare its milligram content. It presents its physical character: the medium in which it is carried, the rate at which active material becomes available, the duration over which effects unfold. These are properties of the prepared form, and they shape the encounter as directly as they ever did.
Modern cannabis use has largely separated dose vocabulary from preparation vocabulary. Dose is discussed in milligrams; preparation is treated as secondary, relevant mainly to bioavailability. That separation is coherent in language but incomplete in practice. A patient taking a given milligram count in a rapidly absorbed tincture and the same count in a slowly releasing fat-based preparation is not receiving the same dose twice in different packaging. Onset timing, duration, peak intensity, and correction window are all different. The form is contributing to every dimension of the encounter, whether the dose vocabulary acknowledges it or not.
Traditional systems did not make this separation because it had no practical meaning in the context they were working in. The form was the primary unit of reference. Quantity mattered within that frame, but it was the form that determined whether the quantity was tolerable, appropriate, and suited to the situation at hand. Modern medicine gained an enormous amount by making quantity measurable and communicable. What it periodically misplaces in that gain is the recognition that the form has not stopped speaking. The body encounters a prepared material, not an abstracted number. Form carries information that quantity alone cannot express, and that information continues to shape response whether or not the current dose vocabulary has a place for it.
References & Citations and What They Support
O’Shaughnessy, W. B. (1843). “On the Preparations of the Indian Hemp, or Gunjah.” Provincial Medical Journal and Retrospect of the Medical Sciences, 5(123), 363–369.
O’Shaughnessy’s revised publication of his 1839 Bengal work describes cannabis preparations, animal observations, clinical use, and the movement toward measured tincture-style administration.
Supports: O’Shaughnessy anchors the article’s transition point, where cannabis dose begins moving from prepared-form judgment toward measured, repeatable administration.
India Hemp Drugs Commission. (1894–1895). Report of the Indian Hemp Drugs Commission, 1893–94, Vol. 1. Calcutta: Government Central Printing Office.
The commission separated bhang, ganja, and charas as distinct hemp drug forms and investigated their preparation, use, effects, social contexts, and regulatory significance.
Supports: Bhang, ganja, and charas provide the article’s clearest evidence for separate practical dose categories rather than interchangeable plant products.
Chopra, R. N., & Chopra, I. C. (1957). “The Use of the Cannabis Drugs in India.” Bulletin on Narcotics, 9(1), 4–29.
This mid-twentieth-century review describes Indian cannabis preparations, including bhang, ganja, and charas, and distinguishes them by plant part, resin content, preparation method, and customary use.
Supports: Leaf, flowering-top, resinous, and prepared cannabis forms could carry different expectations of use, strength, and handling before modern chemical measurement existed.
Touw, M. (1981). “The Religious and Medicinal Uses of Cannabis in China, India and Tibet.” Journal of Psychoactive Drugs, 13(1), 23–34.
Touw surveys religious and medicinal cannabis use across Asian traditions, including the persistence of distinct preparation forms and the historical embedding of cannabis within formal systems of practice.
Supports: Traditional cannabis use can be read as a form-based practice shaped by transmitted preparation categories, not as a precursor to modern milligram dosing.
Lucas, C. J., Galettis, P., & Schneider, J. (2018). “The Pharmacokinetics and the Pharmacodynamics of Cannabinoids.” British Journal of Clinical Pharmacology, 84(11), 2477–2482.
This review explains that cannabinoid effects depend on formulation, route of administration, absorption, distribution, metabolism, and timing of exposure.
Supports: Modern cannabinoid pharmacokinetics reinforces the article’s closing point that response is shaped by formulation and route, not milligram quantity alone.
Full References & Citations
Chopra, R. N., & Chopra, I. C. (1957). The use of the cannabis drugs in India. Bulletin on Narcotics, 9(1), 4–29.
India Hemp Drugs Commission. (1894–1895). Report of the Indian Hemp Drugs Commission, 1893–94 (Vol. 1). Calcutta: Government Central Printing Office.
Lucas, C. J., Galettis, P., & Schneider, J. (2018). The pharmacokinetics and the pharmacodynamics of cannabinoids. British Journal of Clinical Pharmacology, 84(11), 2477–2482.
O’Shaughnessy, W. B. (1843). On the preparations of the Indian hemp, or gunjah. Provincial Medical Journal and Retrospect of the Medical Sciences, 5(123), 363–369.
Touw, M. (1981). The religious and medicinal uses of Cannabis in China, India and Tibet. Journal of Psychoactive Drugs, 13(1), 23–34.
